Adriamycin-cyclophosphamide treatment of squamous cell carcinoma of the cervix

D. S. Alberts, R. Ignoffo

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

In view of the high response rates (ie, up to 60% partial remissions) achieved in advanced cervical cancer with mitomycin C-vincristine-bleomycin and bleomycin methotrexate, the poor results of our study suggest that the adriamycin-cyclophosphamide combination has no important role in the treatment of this disease.

Original languageEnglish (US)
Pages (from-to)143-144
Number of pages2
JournalCancer Treatment Reports
Volume62
Issue number1
StatePublished - Jan 1 1978

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Adriamycin-cyclophosphamide treatment of squamous cell carcinoma of the cervix'. Together they form a unique fingerprint.

  • Cite this